Chicago Partners Investment Group’s Perspective Therapeutics CATX Stock Holding History

Chicago Partners Investment Group’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,450	Closed	-$20K	–	574
2021 Q3	$20K	Hold	3,450	–	–	﹤0.01%	581
2021 Q2	$24K	Hold	3,450	–	–	﹤0.01%	529
2021 Q1	$33K	Hold	3,450	–	–	﹤0.01%	517
2020 Q4	$77K	Hold	3,450	–	–	0.01%	461
2020 Q3	$14K	Hold	3,450	–	–	﹤0.01%	411
2020 Q2	$24K	Hold	3,450	–	–	﹤0.01%	385
2020 Q1	$19K	Hold	3,450	–	–	﹤0.01%	353
2019 Q4	$29K	Hold	3,450	–	–	﹤0.01%	363
2019 Q3	$10K	Hold	3,450	–	–	﹤0.01%	333
2019 Q2	$14K	Hold	3,450	–	–	﹤0.01%	319
2019 Q1	$13K	Buy	+3,450	New	+$13.5K	﹤0.01%	312

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HPWM

Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TMWM

Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chicago Partners Investment Group's CATX Position: Q4 2021 in Review

Chicago Partners Investment Group sold out of Perspective Therapeutics (CATX) in Q4 2021, closing a stake of 3,450 shares — an estimated $20K sold.

Chicago Partners Investment Group first reported a position in CATX in Q1 2019 and held it in 11 quarters. The position peaked at $77K in Q4 2020. 45 funds tracked by Wall St. Rank hold CATX as of Q4 2021.

Chicago Partners Investment Group reported no remaining Perspective Therapeutics position as of Q4 2021 after selling out during the quarter.
Chicago Partners Investment Group sold 3,450 Perspective Therapeutics shares in Q4 2021, an estimated $20K.
Chicago Partners Investment Group first reported a position in Perspective Therapeutics in Q1 2019 and held it in 11 quarters.
Chicago Partners Investment Group's Perspective Therapeutics position peaked at $77K in Q4 2020.
45 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2021.

Based on Chicago Partners Investment Group's 13F filing for Q4 2021, filed 15 Feb 2022.